Midi Health Raises $25M in Series A Funding Led by GV (Google Ventures) to Expand Access to Expert and Affordable Midlife Care for Women
The Leading Virtual Clinic Delivering Insurance-Covered, Expert Care for Women Perimenopause and Menopause, Midi Health Plans Major Expansion of National Footprint Midi Health, the emerging digital leader in women’s midlife healthcare, today announced the close of a $25M Series A funding round led by GV (Google Ventures). Investors Frederique Dame and Cathy Friedman from GV are joined by current investors Felicis, Semper Virens, Icon, 25M, and Operator Collective, bringing the company’s total funding raised to date to $40M. In the year since the company officially launched to consumers, Midi Health has...
Source: EMR and HIPAA - October 16, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT 25M Cathy Friedman Felicis Frederique Dame Google Ventures GV Health IT Funding Health IT Fundings Health IT Investment ICON Joanna Strober Midi Health Operator Collective Semper Virens Source Type: blogs

Fight Aging! Newsletter, October 16th 2023
In conclusion, a number of studies have shown that CD4+ Treg cells are crucial in the maintenance of peripheral tolerance and have an important role in the control of atherosclerosis-related inflammation. Therefore, Treg cells are a promising target of major research efforts focused on immune-modulating therapies against atherosclerosis. Developing anti-atherosclerotic Treg-based therapies faces challenges. However, rapid progress in genetic, epigenetic, and molecular aspects of cellular immunology gives hope for a fast-track solution. « Back to Top Delivering Senolytic Nanoparticles to Atheroscle...
Source: Fight Aging! - October 15, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Why I left medicine – and why AI might convince me to return
My first job as a physician assistant was in a neuro-oncology department. I was young, newly certified, and eager to interact with patients. The physician who mentored me there made sure I had the opportunity to counsel patients, and provide guidance and comfort after a new diagnosis. These are situations where a clinician needs time Read more… Why I left medicine – and why AI might convince me to return originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - October 14, 2023 Category: General Medicine Authors: Tags: Tech Health IT Source Type: blogs

Towards More Selective Ways to Block Unwanted Inflammation
Control of chronic inflammation may turn out to be one of the more important themes in the treatment of aging as a medical condition. Senescent cells generate inflammatory signaling, but removing that contribution is likely the easiest aspect of the problem. Many forms of age-related cellular damage and dysfunction generate constant, unwanted, excess inflammation through interactions and signals that are used during a normal, desirable inflammatory reaction, such as to injury or infection. Thus interfering in these mechanisms must be very selective; simply blockading a given signal has undesirable side-effects, such as a w...
Source: Fight Aging! - October 13, 2023 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

The Popular Weight Loss Drug That Also Fight Cancer
A popular drug that treats obesity may also help to destroy cancer cells. (Source: PsyBlog | Psychology Blog)
Source: PsyBlog | Psychology Blog - October 12, 2023 Category: Psychiatry & Psychology Authors: Mina Dean Tags: Cancer Source Type: blogs